Halozyme Therapeutics Inc. (HALO)

$ 70.43
   
  • Change Today:
    $-0.79
  • 52 Week High: $70.58
  • 52 Week Low: $69.53
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 342,422
  • Market Cap: $10,233m
  • RiskGrade: 189
  • Beta: 0.00

Financial Analysis

Select chart: EPS | Revenue

Key Fundamentals

Fundamentals data is not available for this company.

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,691.05 1,090.47 819.20¢ 8.7 0.3 +31% n/a 0.0%
31-Dec-27 1,909.55 1,307.58 962.50¢ 7.4 0.4 +18% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 70.43
Change Today $ -0.79
% Change -1.10 %
52 Week High $70.58
52 Week Low $69.53
Volume 342,422
Shares Issued 145.30m
Market Cap $10,233m
Beta 0.00
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 20-Jan-2026

Time Volume / Share Price
12:04 100 @ $70.43
12:03 100 @ $70.41
12:03 100 @ $70.41
12:03 100 @ $70.41
12:02 100 @ $70.41

Top of Page